Cart
sales@molnova.com
S107
CAS No. 927871-76-9
S107 ( —— )
Catalog No. M17667 CAS No. 927871-76-9
S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | In Stock |
|
| 5MG | 87 | In Stock |
|
| 10MG | 132 | In Stock |
|
| 25MG | 240 | In Stock |
|
| 50MG | 402 | In Stock |
|
| 100MG | 573 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameS107
-
NoteResearch use only, not for human use.
-
Brief DescriptionS107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.
-
DescriptionS107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number927871-76-9
-
Formula Weight209.31
-
Molecular FormulaC11H15NOS
-
Purity98%
-
SolubilityDMSO : ≥ 38 mg/mL; 181.55 mM
-
SMILESCN1CCSc2c(C1)cc(cc2)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lehnart SE, et al. J Clin Invest. 2008 Jun;118(6):2230-45.
molnova catalog
related products
-
Geraniol
geraniol?provides a potent protective effect against cardiac dysfunction induced by diabetes. This ameliorative effect could be attributed to its suppression of oxidative stress.
-
Isocorynoxeine
Isocorynoxeine shows the effects of lowering blood pressure, vasodilatation, and protection against ischemia-induced neuronal damage.
-
Alendronate sodium h...
Alendronate sodium hydrate (Alendronate;MK 217;G-704650 Adronat) is a bisphosphonate that acts as a specific inhibitor of osteoclastmediated bone resorption.
